Related Experiment Video
Updated: Mar 18, 2026
08:34
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
10.8K
Telomeres, Telomerase and Leukaemia.
X R Jiang1, S M Kelsey1, A C Newland1
1a Department of Haematology , St Bartholomew's and the Royal London School of Medicine and Dentistry , Turner St, London El 2AD , U.K.
Hematology (Amsterdam, Netherlands)
|July 14, 2016
Summary
Telomere shortening signals cellular aging, but cancer cells activate telomerase to maintain length. In leukemias, telomere length and telomerase activity may indicate disease progression and prognosis.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Biology
Background:
- Telomere shortening is a key factor in cellular senescence.
- Telomerase activation is crucial for overcoming senescence and is observed in most cancers.
Purpose of the Study:
- To investigate the role of telomere shortening and telomerase activity in leukemia progression.
- To explore telomerase as a potential diagnostic and therapeutic marker for leukemias.
Main Methods:
- Analysis of telomere length in various leukemia types.
- Measurement of telomerase activity in leukemia cells.
- Correlation of telomere/telomerase status with clinical parameters and prognosis.
Main Results:
- Telomere reduction is observed in several leukemias, potentially indicating disease duration.
- Elevated telomerase activity is found in various leukemias.
- In acute myeloid leukemia (AML), higher telomerase activity correlates with unfavorable prognosis and specific chromosomal abnormalities.
Conclusions:
- Telomere dynamics and telomerase activity are implicated in leukemia progression.
- Telomerase may serve as a prognostic marker in AML.
- Further research is needed to elucidate the full diagnostic and therapeutic potential of telomerase in leukemias.
More Related Videos
Related Concept Videos
02:41Telomeres and Telomerase
28.2K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
28.2K
02:41Telomeres and Telomerase
7.8K
7.8K
02:15Replicative Cell Senescence
4.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
01:29Replication in Eukaryotes
18.6K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
18.6K
02:31Replication in Eukaryotes
206.9K
Overview
206.9K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K